tiprankstipranks
Trending News
More News >
Opyl Ltd. (AU:OPL)
ASX:OPL
Australian Market

Opyl Ltd. (OPL) Price & Analysis

Compare
2 Followers

OPL Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

28.81%71.19%
28.81% Insiders
Mutual Funds
― Other Institutional Investors
71.19% Public Companies and
Individual Investors

OPL FAQ

What was Opyl Ltd.’s price range in the past 12 months?
Opyl Ltd. lowest share price was AU$0.01 and its highest was AU$0.03 in the past 12 months.
    What is Opyl Ltd.’s market cap?
    Opyl Ltd.’s market cap is AU$4.93M.
      When is Opyl Ltd.’s upcoming earnings report date?
      Opyl Ltd.’s upcoming earnings report date is Aug 27, 2025 which is in 71 days.
        How were Opyl Ltd.’s earnings last quarter?
        Opyl Ltd. released its earnings results on Feb 27, 2025. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.004.
          Is Opyl Ltd. overvalued?
          According to Wall Street analysts Opyl Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Opyl Ltd. pay dividends?
            Opyl Ltd. does not currently pay dividends.
            What is Opyl Ltd.’s EPS estimate?
            Opyl Ltd.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Opyl Ltd. have?
            Opyl Ltd. has 234,968,320 shares outstanding.
              What happened to Opyl Ltd.’s price movement after its last earnings report?
              Opyl Ltd. reported an EPS of -AU$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Opyl Ltd.?
                Currently, no hedge funds are holding shares in AU:OPL

                Company Description

                Opyl Ltd.

                Opyl Ltd. (OPL) is an Australian technology company that specializes in improving clinical trials and healthcare outcomes through the use of artificial intelligence and digital tools. The company operates within the biotechnology and healthcare sectors, offering services that leverage data analytics to enhance the efficiency and success rates of clinical trials, as well as digital marketing and insights services tailored for healthcare organizations.
                Similar Stocks
                Company
                Price & Change
                Follow
                Imugene Limited
                PYC Therapeutics Limited
                Race Oncology Ltd.
                Cryosite Limited
                Australian Clinical Labs Ltd
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis